WAYNE, Pa.--Escalon Medical (Nasdaq: ESMC) had net revenues of $26.9 million in its fourth quarter ended June 30, an 82.9 percent increase over fiscal 2004’s Q4.

The increase was primarily attributable to revenues resulting from the July 2004 acquisition of Drew Scientific Group, the company said. Product revenue increased 93.3 percent, to $23.8 million, in fiscal 2005, primarily attributable to Drew.